Concepedia

Premixed insulin aspart 30 (Biasp 30) vs. premixed human insulin 30 (BHI 30) in gestational diabetes mellitus--a pilot study.

Vijayam Balaji, Madhuri S Balaji, Cynthia Alexander, S. Ashalata, R Sheela Suganthi, S Suresh, V Seshiah

PubMed · 2010 · 12 citations · 6 references

Abstract

BIAsp was safe during pregnancy and pregnant women found it convenient due to meal time dosing. Fetal outcome using BIAsp was also comparable with BHI 30.

References

6

Birth weight and non-insulin dependent diabetes: thrifty genotype, thrifty phenotype, or surviving small baby genotype?

David R. McCance, David J. Pettitt, Robert L. Hanson et al. · BMJ · 1994 · 693 citations

Maternal postprandial glucose levels and infant birth weight: The Diabetes in Early Pregnancy Study

Lois Jovanovic‐Peterson, Charles M. Peterson, Boyd E. Metzger et al. · American Journal of Obstetrics and Gynecology · 1991 · 409 citations

, , +14

Glycemic control in gestational diabetes mellitus-How tight is tight enough: Small for gestational age versus large for gestational age?

Oded Langer, Judith Levy, Lois Brustman et al. · American Journal of Obstetrics and Gynecology · 1989 · 376 citations

, , +8

Fetal and perinatal outcomes in type 1 diabetes pregnancy: a randomized study comparing insulin aspart with human insulin in 322 subjects

Moshe Hod, Peter Damm, Risto Kaaja et al. · American Journal of Obstetrics and Gynecology · 2007 · 172 citations

, , +11

Risk and prevention of type 2 diabetes in women with gestational diabetes.

Anne Dornhorst, Maryann W. Rossi · PubMed · 1998 · 164 citations

, , +14